drugset / Trial / NCT01775098

Allopurinol in Acute Gout

NCT01775098

RandomizedParallel-groupTriple-blindTreatment

Summary

The objectives of the present study are to determine if starting treatement of hyperuricemia with allopurinol during an acute gout crises has an impact on the duration or the severity of the crises

Timeline

Start
Primary completion
2012-12
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Allopurinol Small molecule

Indications